Since we had previously found that knockdown of CD276 inhibited theactivation of the FAK-MAPK pathway in the ccRCC cell model, we further exploredwhether knockdown of CD276 could have a similar effect in vivo. The gene discussed is PTK2; the disease is nonpapillary renal cell carcinoma.